logo
Toronto city staff scale back proposal for priority bus lane on Dufferin, Bathurst streets

Toronto city staff scale back proposal for priority bus lane on Dufferin, Bathurst streets

CBC4 days ago
Toronto city staff are curtailing proposed plans for dedicated bus lanes along Bathurst and Dufferin streets, according to a report going to council's executive committee later this month.
The report, which will be considered on July 16, recommends bus-only lanes be installed on Dufferin Street from King Street W. up to Bloor Street W. — not up to Eglinton Avenue W. as initially proposed.
It similarly recommends bus-only lanes be installed on Bathurst Street from Lake Shore Boulevard W. north to Bloor Street, except for the stretch between Nassau Street and Dundas Street W., where construction is ongoing at the Toronto Western Hospital.
The Dufferin proposal sparked mixed reaction from residents in the spring, who raised concerns over the loss of parking spaces and congestion during a virtual town hall.
WATCH | Reaction mixed over proposed bus lanes on 2 major Toronto streets:
'It's desperately needed': Bathurst and Dufferin could get priority bus lanes
2 months ago
Duration 2:19
The city is considering installing priority bus lanes on two major Toronto streets. But as Tyler Cheese explains, some say the decision is being rushed without properly consulting those who will be most affected.
At the time, Philip Morse, senior project manager for the city's transportation services, told attendees that "What we saw in the data is that Dufferin is congested, Dufferin is slow and Dufferin needs to be better."
According to the city staff report, the priority lanes would see 75 parking spaces removed along Dufferin Street and 277 parking spaces on Bathurst Street.
It would require an estimated $8 million in capital funding to make the changes, the city staff report says.
If approved by the executive committee, the proposal would go before city council. If approved by city council, the report suggests construction would begin this fall with an estimated completion in the spring of 2026.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Biotech entrepreneur Francesco Bellini uplifted the next generation of Canadian scientists
Biotech entrepreneur Francesco Bellini uplifted the next generation of Canadian scientists

Globe and Mail

time3 hours ago

  • Globe and Mail

Biotech entrepreneur Francesco Bellini uplifted the next generation of Canadian scientists

Francesco Bellini, one of Canada's most successful biotechnology entrepreneurs, has died, leaving behind a legacy of life-saving work and opportunity for those following in his footsteps. Mr. Bellini, who died on Thursday in Calgary after a cardiac arrest earlier in the week, came to Canada as an Italian immigrant in 1967. He settled in Quebec where he co-founded BioChem Pharma Inc. There, he would go on to raise Canada's presence in biopharmaceutical research on the global stage through the development and commercialization of the 3TC molecule, which remains a critical ingredient in the drug used to treat HIV/AIDS. 'He was Mr. biotech Canada. There's no doubt about that,' said Pierre Larochelle, co-managing partner at Idealist Capital, who worked closely with Mr. Bellini for many years. In 2001, Mr. Bellini sold BioChem for $5.9-billion in a transaction that set the bar for the industry and it remains highly regarded to this day as an 'Everest of achievement,' said Brian Bloom, CEO of Toronto life sciences underwriter Bloom Burton & Co. Mr. Bellini carried on leading and investing in companies until he settled into his final major professional role as chair of Bellus Health Inc., with his son Roberto at the reins as CEO. In 2023, the family sold Bellus to British drug giant GSK PLC for US$2-billion. Clarissa Desjardins, CEO of Congruence Therapeutics, met Mr. Bellini 30 years ago as a young life sciences entrepreneur. In addition to his encouragement of her generation, she said his trajectory from a young immigrant to the head of a Canadian pharmaceutical empire always stuck with her. 'It's quite a legacy of him showing us what was possible,' she said. Mr. Larochelle said that Mr. Bellini constantly displayed a sense of courage, which had a great influence on him as an entrepreneur and now father. 'He was always undertaking something,' he said. 'Whatever it was, from a business standpoint or personal standpoint, he was always trying something and building something.' Despite the many trials and tribulations Mr. Bellini faced throughout his career, Mr. Larochelle said it's worth noting that he never compromised on his commitment to his wife and two sons. 'What defined him is he was able to do that, achieve extraordinary success, while staying a very close family and an exceptional husband and father,' he said. And in circumstances where Mr. Bellini's work and family life collided, Dr. Desjardins said he honourably upheld this trait. For example, if he ever disagreed with a decision being made at Bellus, he would voice his opinion and then defer to his son or the board for a final call, setting his pride aside. 'It showed a lot of leadership, maturity and, frankly, love,' she said. Outside of life sciences, and even Canada, Mr. Bellini held the status of a local celebrity in Ascoli Piceno, Italy, the small town where his family was from, after he bought the soccer team there in 2014. Walking through the streets with him after that purchase is one of long-time friend and former Air Canada CEO Calin Rovinescu's fondest memories of the entrepreneur. 'He was celebrated on the streets literally like a rock star,' Mr. Rovinescu said. 'It was as if we were walking with Brad Pitt through the centre of the town. People stopping, taking pictures, asking for his autograph. Other pursuits of note for Mr. Bellini included a winery he and his wife, Marisa, established in Italy and an olive-oil business. In the early days of Mr. Bellini's career, Mr. Rovinescu said a portrait of Albert Einstein sat nearby the scientist's desk, with a famous quote plastered on it reminding him not to take no for an answer. That motto of persistence, he said, no matter the number of failures Mr. Bellini faced, became a cornerstone of his character – one which people all over the world continue to benefit from today. Whether someone has received a treatment made possible by his work, or is one of the scores of young scientists given a chance because of a company Mr. Bellini built or invested in, Mr. Rovinescu said his legacy will continue to be wide-reaching for decades to come. 'When you look at the net effect of all that, that could be millions of lives that would have been enhanced through his contribution to science.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store